Ghent University Academic Bibliography

Your filters: cql: author="Delrée, Paul" or (type any "bookEditor issueEditor" and editor="Delrée, Paul")

Add to list
- Journal Article
- A1
- open access
Identification by array comparative genomic hybridization of a new amplicon on chromosome 17q highly recurrent in BRCA1 mutated triple negative breast cancer

Sébastien Toffoli, Isabelle Bar, Fadi Abdel-Sater, Paul Delrée, Pascale Hilbert, Frédéric Cavallin, Fabrice Moreau, Wim Van Criekinge (UGent) , Magali Lacroix-Triki, Mario Campone, et al.

(2014) BREAST CANCER RESEARCH. 16(6).
Add to list
Clinical utility of an epigenetic assay to detect occult prostate cancer in histopathologically negative biopsies: results of the MATLOC study

Grant D Stewart, Leander Van Neste (UGent) , Philippe Delvenne, Paul Delrée, Agnès Delga, S Alan McNeill, Marie O'Donnell, James Clark, Wim Van Criekinge (UGent) , Joseph Bigley, et al.

(2013) JOURNAL OF UROLOGY. 189(3). p.1110-1116
Add to list
- Journal Article
- A1
- open access
A tissue biopsy-based epigenetic multiplex PCR assay for prostate cancer detection

Leander Van Neste (UGent) , Joseph Bigley, Adam Toll, Gaëtan Otto, James Clark, Paul Delrée, Wim Van Criekinge (UGent) and Jonathan I Epstein

(2012) BMC UROLOGY. 12.
Add to list
Phosphorylated HER-2 tyrosine kinase and Her-2/neu gene amplification as predictive factors of response to trastuzumab in patients with HER-2 overexpressing metastatic breast cancer (MBC)

Rosa Giuliani, Virginie Durbecq, Angelo Di Leo, Marianne Paesmans, Denis Larsimont, Jean-Yves Leroy, Marleen Borms, Anita Vindeuoghel, Guy Jerusalem, Veronique D'Hondt, et al.

(2007) EUROPEAN JOURNAL OF CANCER. 43(4). p.725-735

Academic Bibliography

Identification by array comparative genomic hybridization of a new amplicon on chromosome 17q highly recurrent in BRCA1 mutated triple negative breast cancer

Clinical utility of an epigenetic assay to detect occult prostate cancer in histopathologically negative biopsies: results of the MATLOC study

A tissue biopsy-based epigenetic multiplex PCR assay for prostate cancer detection

Phosphorylated HER-2 tyrosine kinase and Her-2/neu gene amplification as predictive factors of response to trastuzumab in patients with HER-2 overexpressing metastatic breast cancer (MBC)

Contents

Support

Contact